Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

GUJARAT ALKALIES vs STERLING BIOTECH - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    GUJARAT ALKALIES STERLING BIOTECH GUJARAT ALKALIES/
STERLING BIOTECH
 
P/E (TTM) x -42.1 -0.0 - View Chart
P/BV x 0.9 0.1 1,193.2% View Chart
Dividend Yield % 3.1 0.0 -  

Financials

 GUJARAT ALKALIES   STERLING BIOTECH
EQUITY SHARE DATA
    GUJARAT ALKALIES
Mar-23
STERLING BIOTECH
Mar-18
GUJARAT ALKALIES/
STERLING BIOTECH
5-Yr Chart
Click to enlarge
High Rs1,0457 15,432.1%   
Low Rs5562 33,905.5%   
Sales per share (Unadj.) Rs615.012.7 4,852.5%  
Earnings per share (Unadj.) Rs55.8-36.9 -151.0%  
Cash flow per share (Unadj.) Rs93.4-27.9 -334.5%  
Dividends per share (Unadj.) Rs23.550-  
Avg Dividend yield %2.90-  
Book value per share (Unadj.) Rs836.010.1 8,247.9%  
Shares outstanding (eoy) m73.44272.17 27.0%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x1.30.3 392.2%   
Avg P/E ratio x14.3-0.1 -12,605.7%  
P/CF ratio (eoy) x8.6-0.2 -5,689.6%  
Price / Book Value ratio x1.00.4 230.8%  
Dividend payout %42.20-   
Avg Mkt Cap Rs m58,7791,144 5,135.9%   
No. of employees `000NANA-   
Total wages/salary Rs m2,524583 432.7%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m45,1653,449 1,309.4%  
Other income Rs m42255 766.3%   
Total revenues Rs m45,5873,504 1,300.8%   
Gross profit Rs m9,485-7,582 -125.1%  
Depreciation Rs m2,7612,457 112.3%   
Interest Rs m1954,397 4.4%   
Profit before tax Rs m6,951-14,381 -48.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,855-4,327 -66.0%   
Profit after tax Rs m4,096-10,054 -40.7%  
Gross profit margin %21.0-219.8 -9.6%  
Effective tax rate %41.130.1 136.5%   
Net profit margin %9.1-291.5 -3.1%  
BALANCE SHEET DATA
Current assets Rs m14,0984,807 293.3%   
Current liabilities Rs m8,39956,226 14.9%   
Net working cap to sales %12.6-1,490.7 -0.8%  
Current ratio x1.70.1 1,963.5%  
Inventory Days Days1741,685 10.3%  
Debtors Days Days230543 42.3%  
Net fixed assets Rs m69,25065,836 105.2%   
Share capital Rs m734272 269.8%   
"Free" reserves Rs m60,6582,486 2,439.6%   
Net worth Rs m61,3922,759 2,225.5%   
Long term debt Rs m4,58919,787 23.2%   
Total assets Rs m83,34770,643 118.0%  
Interest coverage x36.7-2.3 -1,616.8%   
Debt to equity ratio x0.17.2 1.0%  
Sales to assets ratio x0.50 1,109.8%   
Return on assets %5.1-8.0 -64.3%  
Return on equity %6.7-364.5 -1.8%  
Return on capital %10.8-44.3 -24.5%  
Exports to sales %16.122.8 70.6%   
Imports to sales %10.60.6 1,774.9%   
Exports (fob) Rs m7,257785 924.0%   
Imports (cif) Rs m4,77521 23,237.8%   
Fx inflow Rs m7,257785 924.0%   
Fx outflow Rs m5,27126 20,073.6%   
Net fx Rs m1,986759 261.6%   
CASH FLOW
From Operations Rs m9,600-328 -2,926.2%  
From Investments Rs m-6,609-91 7,224.1%  
From Financial Activity Rs m-1,403384 -364.9%  
Net Cashflow Rs m1,578-35 -4,485.1%  

Share Holding

Indian Promoters % 46.3 24.6 187.8%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 5.2 21.9 23.9%  
FIIs % 2.1 7.5 27.9%  
ADR/GDR % 0.0 0.0 -  
Free float % 53.7 75.4 71.3%  
Shareholders   82,719 35,184 235.1%  
Pledged promoter(s) holding % 0.0 55.9 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare GUJARAT ALKALIES With:   PIDILITE INDUSTRIES    SRF    BALAJI AMINES    YASHO INDUSTRIES    ALKYL AMINES    


More on Gujarat Alkalies vs Sterling Biotech

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Gujarat Alkalies vs Sterling Biotech Share Price Performance

Period Gujarat Alkalies Sterling Biotech
1-Day -0.54% -4.94%
1-Month -4.28% 6.94%
1-Year 16.81% -78.61%
3-Year CAGR 23.51% -46.43%
5-Year CAGR 6.54% -32.29%

* Compound Annual Growth Rate

Here are more details on the Gujarat Alkalies share price and the Sterling Biotech share price.

Moving on to shareholding structures...

The promoters of Gujarat Alkalies hold a 46.3% stake in the company. In case of Sterling Biotech the stake stands at 24.6%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Gujarat Alkalies and the shareholding pattern of Sterling Biotech.

Finally, a word on dividends...

In the most recent financial year, Gujarat Alkalies paid a dividend of Rs 23.6 per share. This amounted to a Dividend Payout ratio of 42.2%.

Sterling Biotech paid Rs 0.0, and its dividend payout ratio stood at -0.0%.

You may visit here to review the dividend history of Gujarat Alkalies, and the dividend history of Sterling Biotech.



Today's Market

Sensex Today Ends 75 Points Lower | Nifty Above 22,500 | Adani Enterprises Surges 7% Sensex Today Ends 75 Points Lower | Nifty Above 22,500 | Adani Enterprises Surges 7%(Closing)

After opening the day marginally higher, Indian share continued the momentum as the session progressed and ended the day higher.